Travel-Related Economic Burden of Chimeric Antigen Receptor T Cell Therapy Administration by Site of Care

INTRODUCTION: We previously examined how expanding access to chimeric antigen receptor (CAR) T cell therapy administration sites impacted patient travel distances and time. In the current study, we estimated travel-related economic burden associated with site-of-care options among patients with rela...

Descripción completa

Detalles Bibliográficos
Autores principales: Snyder, Sophie, Albertson, Tina, Garcia, Jacob, Gitlin, Matthew, Jun, Monika P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342383/
https://www.ncbi.nlm.nih.gov/pubmed/34279805
http://dx.doi.org/10.1007/s12325-021-01839-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342383/
https://www.ncbi.nlm.nih.gov/pubmed/34279805
http://dx.doi.org/10.1007/s12325-021-01839-y

Ejemplares similares